The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
A new prognostic model of survival in second-line targeted therapy (TT) for metastatic renal cell carcinoma (mRCC).
 
Lisa Derosa
No Relationships to Disclose
 
Mohamed Amine Bayar
No Relationships to Disclose
 
Laurence Albiges
Consulting or Advisory Role - Amgen; Bayer; Bristol-Myers Squibb; Novartis; Pfizer; Sanofi
Research Funding - Novartis (Inst); Pfizer (Inst)
 
Christophe Massard
No Relationships to Disclose
 
Yohann Loriot
No Relationships to Disclose
 
Karim Fizazi
Honoraria - Astellas Pharma; Janssen; Sanofi; Takeda
Consulting or Advisory Role - Astellas Pharma; Bayer; Curevac; Dendreon; Ipsen; Janssen Oncology; Novartis; Orion; Sanofi; Takeda
Travel, Accommodations, Expenses - Amgen
 
Gwenael Le Teuff
No Relationships to Disclose
 
Bernard J. Escudier
Honoraria - Bayer; GlaxoSmithKline; Novartis; Pfizer
Consulting or Advisory Role - Bayer; Bristol-Myers Squibb; Exelixis; GlaxoSmithKline; Novartis; Pfizer